Press Releases

Press Releases: RAFARMA PHARMACEUTICALS INC

Rafarma Closes Exclusive Joint Venture Contract with Thailand Cannabis Partner

January 21, 2020

Ljubljana, Slovenia, Jan. 21, 2020 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. “OTC:(RAFA)” is happy to announce the execution of an exclusive joint venture agreement with MTP MATERIAL CO. LTD. (“MTP”). This marks the first time a U.S. company has entered the Thailand cannabis industry with an agreement of this kind. Read More

Rafarma Adds Thai Corporate Officer to Solidify Market Entry in Thailand Cannabis Industry

January 9, 2020

Ljubljana, Slovenia, Jan. 09, 2020 (GLOBE NEWSWIRE) -- RAFARMA PHARMACEUTICALS INC. “OTC:(RAFA)”. Rafarma Pharmaceuticals, Inc. is pleased to welcome a new Executive Vice-President for Thai operations, Mr. Anucha Phetpheng. Mr. Phetpheng, 55, resides both in Bangkok and Phuket, Thailand with his wife and three children. Mr. Phetpheng brings to the company an extensive experience of top management positions in several Thailand-based companies. In Rafarma Pharmaceuticals, Mr. Phetpheng will be instrumental in running the upcoming Thai operations of the company and in getting the most synergy between the company’s European and Thai cannabis cultivation operations. Read More

Rafarma Establishes Early Market Entry in Thailand Cannabis Industry; Signs Letter of Intent to Acquire Major Interest in Established Thailand Cultivator

November 8, 2019

Ljubljana, Slovenia, Nov. 08, 2019 (GLOBE NEWSWIRE) -- RAFARMA PHARMACEUTICALS INC. “OTC:(RAFA)” Rafarma Pharmaceuticals, Inc. announces that following meetings this past week in Bangkok and Khon Kaen, Thailand, it has signed a Letter of Intent to acquire a 49% interest in a Thailand company which is already positioned to be a leader in the Thailand cannabis industry. Read More

Rafarma Announces the Cancellation of All Outstanding Preferred A Shares, Removing Obstacles to Further Growth

September 3, 2019

Ljubljana, Slovenia, Sept. 03, 2019 (GLOBE NEWSWIRE) -- RAFARMA PHARMACEUTICALS INC. “OTC:(RAFA)” - Rafarma Pharmaceuticals, Inc. announces the cancellation of all outstanding Preferred Class A shares. On August 28th, 2019, The company’s Board of Directors unanimously voted to cancel the 30,000,000 previously-issued Class A Preferred Shares. Read More]

Rafarma to Commence Production in Thailand; Predicted to Be The Region’s “Cannabis Capital”

August 23, 2019

Ljubljana, Slovenia, Aug. 23, 2019 (GLOBE NEWSWIRE) -- RAFARMA PHARMACEUTICALS INC. “OTC:(RAFA) - Rafarma is positioning to expand its operations in the “next big thing” in cannabis production—Thailand. Rafarma is currently in talks with Thai partners to open cannabis farms and specialized cannabis spa and detox centers in Thailand. Projected plans are to construct hemp growing greenhouses as well as a specialized spa/detox center with full-control patient living facilities the following year on approximately 1000 rai (160 hectares) in the Ranong province of Thailand.[Read More]

Rafarma’s Agri-Tech Keeping Cannabis Production “High”

August 22, 2019

Ljubljana, Slovenia, Aug. 22, 2019 (GLOBE NEWSWIRE) -- RAFARMA PHARMACEUTICALS INC. “OTC:(RAFA) - Rafarma is continuing to actively promote its hemp oil products in the European market. Despite the adverse weather conditions in the 2019 growing season, the quality of the company's harvested crop remained high—due to Rafarma’s practice of using only high-quality organic fertilizers and avoiding mineral fertilizers or pesticides. In particular, the use of Agropharm, a water-based extract of bio humus, allows growth production in conditions approximating black humus in virgin land.[Read More]

RAFARMA Welcomes New CEO Vladimir Dolgolenko

July 12, 2019

Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to the appointment of Vladimir Dolgolenko as its new CEO and President. Vladimir G. Dolgolenko, who resides in Slovenia, received his degrees from the Moscow State Foreign Language University (1984) and Moscow Aviation Institute (1989). Mr. Dolgolenko has earned a Masters degree in Economics and is fluent in English, Russian, Spanish and Swedish.[Read More]

RAFARMA’s Blockchain Tech Ready for Thailand’s Approved Uses of Cannabis

July 08, 2019

Ljubljana, Slovenia, July 08, 2019 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. (OTC: RAFA), is pleased to announce the commencement of negotiations with the government of the Kingdom of... [Read More]

RAFARMA Adds Blockchain Tech to Cannabis Distribution

June 19, 2019

Ljubljana, Slovenia, June 19, 2019 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals Inc (OTC: RAFA), a Wyoming Corporation, is pleased to announce an agreement with Aetsoft LLC. Aetsoft is one of the... [Read More]

Rafarma Announces Acquisition of Aeroponic Technology Expecting to Quadruple Production

June 07, 2019

Ljubljana, Slovenia, June 07, 2019 (GLOBE NEWSWIRE) -- Rafarma (OTC: RAFA), a Wyoming Corporation, is pleased to announce that it has entered into a technology acquisition agreement with Dr. Yury... [Read More]

Rafarma: Now “Growing” More Than Ever!

May 31, 2019

Ljubljana, Slovenia, May 31, 2019 (GLOBE NEWSWIRE) -- RAFARMA PHARMACEUTICALS INC. “OTC:(RAFA)”, a Wyoming Corporation, is pleased to announce approval of its application for farming cannabis in... [Read More]

Rafarma Joins with Glorija Kotnik to New Victories

May 30, 2019

Ljubljana, Slovenia , May 30, 2019 (GLOBE NEWSWIRE) -- Rafarma (OTC: RAFA), a Wyoming Corporation, has hired internationally acclaimed professional snowboarder Glorija Kotnik as its spokesperson and... [Read More]